Sure.
Read more
SAN FRANCISCO (Reuters) — Amazon.com Inc is exploring a technology first developed for the U.S. military to produce tasty prepared meals that do not need refrigeration, as it looks for new ways to muscle into the $700 billion U.S. grocery business.
The world’s biggest online retailer has discussed selling ready-to-eat dishes such as beef stew and a vegetable frittata as soon as next year, officials at the startup firm marketing the technology told Reuters.
The dishes would be easy to stockpile and ship because they do not require refrigeration and could be offered quite cheaply compared with take-out from a restaurant.
Read more
Nextbigfuture interviewed Naveen Jain at the Singularity University Global Summit. Naveen K. Jain is a business executive, entrepreneur and the founder and former CEO of InfoSpace and a fonder of Moon Express, Viome, World Innovation Institute, Bluedot, iNome, TalentWise and Intelius. He was Ernst and Young’s Entrepreneur of the Year, Silicon India’s “Most Admired Serial Entrepreneur,” and the receiver of “Albert Einstein Technology Medal” for his pioneers in technology, he has been repeatedly honored for his entrepreneurial successes. Red Herring also recognized him as one of the “Top 20 Serial Entrepreneurs” and with the “Lifetime Achievement Award.” In 2015, Naveen Jain had a net worth of $2.2 billion.
Read more
Researchers at The Ohio State University Wexner Medical Center and Ohio State’s College of Engineering have developed a new technology, Tissue Nanotransfection (TNT), that can generate any cell type of interest for treatment within the patient’s own body. This technology may be used to repair injured tissue or restore function of aging tissue, including organs, blood vessels and nerve cells.
Results of the regenerative medicine study published in the journal Nature Nanotechnology.
“By using our novel nanochip technology, injured or compromised organs can be replaced. We have shown that skin is a fertile land where we can grow the elements of any organ that is declining,” said Dr. Chandan Sen, director of Ohio State’s Center for Regenerative Medicine & Cell Based Therapies, who co-led the study with L. James Lee, professor of chemical and biomolecular engineering with Ohio State’s College of Engineering in collaboration with Ohio State’s Nanoscale Science and Engineering Center.
Read more
